Trial Profile
Bevacizumab, Radiotherapy and Temozolomide Safety study in resected and irresectable primary GBM patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Nov 2017
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Temozolomide
- Indications Glioblastoma
- Focus Adverse reactions; Biomarker
- Acronyms BERTES
- 12 Jul 2011 New trial record